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What is already known on this topic 
Cancer Councils recommend patients conduct regular skin self-examinations for 
melanoma early detection.  Patient-initiated and performed mobile teledermoscopy may 
aid consumers in this process.  
What does this study adds 
Older adults at high risk of melanoma are highly accepting of mobile teledermoscopy. 
However, complete trust in the telediagnosis was a concern among some participants. 
Most participants found mobile teledermoscopy easy to conduct. 
 
Abstract 
Background: Mobile teledermoscopy allows consumers to send images of skin lesions to a 
teledermatologist for remote diagnosis.  Currently, technology acceptance of mobile 
teledermoscopy by people at high risk of melanoma is unknown.   
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Objectives: We aimed to determine acceptance of mobile teledermoscopy by consumers 
based on: perceived usefulness; ease of use; compatibility; attitude, intention; subjective 
norms; facilitators, and trust before use. Satisfaction was explored after use. 
Methods: Consumers 50-64 years at high risk of melanoma (fair skin, or previous skin 
cancer) were recruited from a population-based cohort study and via media announcements in 
Brisbane, Australia in 2013. Participants completed a 27-item questionnaire pre-
teledermoscopy modified from a Technology Acceptance Model. The first 49 participants 
with a suitable Smartphone then conducted mobile teledermoscopy in their homes for early 
detection of melanoma and asked to rate their satisfaction.  
Results: The pre-teledermoscopy questionnaire was completed by 228  participants.  Most 
(87%) participants agreed mobile teledermoscopy would improve their skin self-examination 
performance and 91% agreed it would be in their best interest to use. However nearly half 
(45%) of participants were unsure, if they had complete trust in the telediagnosis. Participants 
who conducted mobile teledermoscopy (n=49) reported the dermatoscope was easy to use 
(94%), motivated them to examine their skin more often (86%), but 18% could not take 
photos in hard to see areas and 35% required help to submit the photo to the 
teledermatologist.  
Conclusions: Mobile teledermoscopy consumer acceptance appears favourable. This new 
technology warrants further assessment for its utility in melanoma early detection or follow-
up. 
 
Key Words: teledermatology, telemedicine, mhealth, smartphones, home health monitoring 
 
Introduction 
Dermatologists diagnose skin conditions, including melanoma, with excellent accuracy based 
on a visual inspection.
1
 Dermatology, therefore, is a medical speciality well suited to 
telemedicine. Teledermatology has been tested in the context of early detection, remote 
clinical diagnosis and patient triage for several dermatological conditions.
2-4
 Benefits of 
telemedicine include increased access to care, reduced waiting time, reduced travel, potential 
cost savings, and efficient referral.
5
 Concerns about teledermatology include lack of direct 
patient contact and insufficient follow-up.
6
 Teledermatology can be performed via live video 
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communication between doctor and patient or via ‘store and forward’ systems.1 The latter 
allow electronic transmission of photographs of skin conditions to a dermatologist for 
diagnosis and management advice and is more easily organised due to time independence of 
the patient and doctor. One application of teledermatology used for melanoma diagnosis is 
mobile teledermoscopy. Mobile teledermoscopy uses a dermatoscope attachment for a 
smartphone, which allows lesion magnification under light and a specialised application (app) 
to simplify the workflow of sending images and clinical information. 
 
As summarised in four reviews, store and forward teledermatology for skin cancer diagnosis 
has high diagnostic accuracy compared with face-to-face diagnosis.
7-10
 In one study on store 
and forward teledermoscopy, 955 lesions (n=690) were diagnosed by two teledermatologists 
with an overall diagnostic accuracy rate of 94%.
11
  
 
Previous studies have assessed satisfaction of teledermatology among general practitioners 
when used to obtain a second opinion from dermatologists.
12-14
 Patient satisfaction with 
teledermatology has been summarised in four reviews. 
6,8,10,15
 Patient satisfaction with store 
and forward teledermatology varied widely, from 42-93%, 
8
 using a range of data collection 
instruments. Only one small pilot study
16
 focused on consumer-driven mobile 
teledermoscopy for melanoma early detection, and participants found the dermatoscope easy 
to use.
 
 
The present study assessed the self-reported consumer technology acceptance of mobile 
teledermoscopy when used for melanoma early detection during skin self-examination (SSE).  
Technology acceptance refers to the consumers attitudes towards mobile teledermoscopy and 
if they would or would not use it. Selected participants with a suitable smartphone trialed the 
dermatoscope at home and their satisfaction with mobile teledermoscopy was assessed both 
quantitatively and qualitatively. 
 
Methods 
 The ethics committees of the Queensland University of Technology (QUT) and QIMR 
Berghofer Research Institute approved the study (QUT approval number 1200000553; QIMR 
approval number PI309). This research used data from the pre and post-teledermoscopy 
surveys.  
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Pre-teledermoscopy survey 
Potential participants between 50-64 years were recruited through the QSkin Sun and Health 
Study (QSkin),
17
 a cohort study conducted in Queensland, Australia to investigate skin cancer 
risk factors.  QSkin enrolled 43,794 participants. Investigators selected a random sample of 
500 QSkin participants to be invited to the current study that lived within the Brisbane area 
and met at least one criterion for high risk of melanoma. These included fair skin, light eye 
colour, numerous dysplastic naevi or history of skin cancer. Potential participants were 
mailed an expression of interest letter to complete the pre-teledermoscopy survey. Of those, 
261 participants and 59 volunteers (who joined the study after a media announcement, and 
also met the inclusion criteria) received a consent form and survey (total n=320). Overall, 
230/320 participants (72%) completed the pre-teledermoscopy survey and returned it by mail. 
Outcome measure pre-teledermoscopy 
Orruno et al.
13
 tested a modified version of the Technology Acceptance Model. Using the 
model, they developed a 33-item multidimensional questionnaire to assess general 
practitioners’ teledermatology acceptance. We adapted this questionnaire for consumer-
driven mobile teledermoscopy and excluded eight items relating to physician practices, and 
added two items assessing trust. Five experts in melanoma research evaluated and approved 
of the instrument face validity.. Cronbach’s alpha for each of the seven domains was 
acceptably high (above recommended 0.70), except for the facilitators (0.68) and 
compatibility (0.48) domains, likely due to small number of items in these domains (3 and 4, 
respectively).   Higher Cronbach alpha scores indicate that the items in a questionnaire 
measure the same construct.  
Response options for the resulting 27-item survey ranged from 5 (strongly agree) to 1 
(strongly disagree), which were collapsed into three categories for reporting: 3=agree (agree/ 
strongly agree), 2=neutral and 1=disagree (disagree/ strongly disagree). Questions were 
summarised in seven domains: perceived usefulness (5 items); perceived ease of use (4 
items); attitude and intention (6 items); compatibility (4 items); facilitators (3 items); 
subjective norms (3 items), and trust (2 items).  
 
Post- teledermoscopy survey 
We assessed diagnostic accuracy of teledermoscopy and satisfaction with patient-performed 
mobile teledermoscopy. Diagnostic accuracy and clinical results were previously reported.
18
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Briefly, among all participants who completed the pre-teledermoscopy survey (n=230), the 
first 58 participants who expressed interest and had access to an iPhone were enrolled and 
mailed the dermatoscope (FotoFinder Systems GmbH, Bad Birnbach, Germany) (Fig. 1). 
They conducted one SSE using mobile teledermoscopy in their homes for melanoma early 
detection. The dermatoscope has both polarised and non-polarised capabilities, participants 
were asked to use the non-polarised option. Data is available for 49 participants. The 49 
participants performed mobile teledermoscopy following written instructions, including 
instructions on how to download the Handyscope app, how to use the dermatoscope to obtain 
and send dermoscopic images, and how to take a second clinical image to verify the 
anatomical location of the lesion. Participants were provided with the Asymmetry and Colour 
(AC) Rule for identifying melanoma
19
 and asked to photograph spots they ‘did not like the 
look of’. Participants submitted their dermoscopic and anatomical images to the study 
researchers from their iPhone via the handyscope app. Photos were reviewed by the study 
dermatologist and dermatology registrar. Participants were asked to return the dermatoscope 
and questionnaire via pre-paid mail. Figure 2 displays participant recruitment and flow 
through the study. 
 
Participants whose differential telediagnosis included skin cancer were provided with their 
results via phone by the study dermatology registrar under supervision of the same 
dermatologist who undertook the telediagnosis. Participants were referred to their regular 
general practitioner or dermatologist if excision was recommended. When the lesions were 
telediagnosed as likely benign, participants were provided with their results at the follow-up 
in-person consultation by the dermatologist within three months of telediagnosis. The follow-
up consultation was conducted to assess the diagnostic accuracy of the telediagnosis 
compared to in-person clinical skin examination and results have been previously reported.
18
 
Participants were provided with a gift voucher (AUD$100) for reimbursement of their time, 
cost of the app, and travel. The clinical outcomes were reported previously.
12
 The 49 
participants who conducted mobile teledermoscopy submitted 309 lesions to the 
teledermatologist (median 5 photos per person, range 0-21). Of the 309 lesions, all but two 
dermoscopic images which were of poor quality, allowed telediagnosis. Participants 
demonstrated an 89% diagnostic agreement between tele-and clinical diagnosis for consumer-
submitted photos of lesions overall, but lesion-based sensitivity (41%) was low owing to 
some lesions being missed by patients that the dermatologist considered worthwhile 
photographing.
18
 Figure 3 displays a dermoscopic image captured by a participant. 
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Outcome measures post-teledermoscopy survey 
The  post-teledermoscopy survey was completed by the 49 participants after using the 
dermatoscope at home, and assessed their satisfaction with mobile teledermoscopy. The 
questions were adapted from a previous study.
16,20
 Forced choice survey questions asked 
participants to rate their confidence conducting SSE alone, or with mobile teledermoscopy, 
any difficulties experienced, if they required help taking photos and if they would use mobile 
teledermoscopy in the future. Participants were asked one open-ended question about their 
opinions on conducting mobile teledermoscopy at home.  
 
Data analysis 
Descriptive statistics were computed for demographic variables and mobile teledermoscopy 
acceptance and satisfaction questions. Fisher’s exact tests were used to measure associations 
between participants’ skin cancer history and mole count with teledermoscopy acceptance. 
Internal consistency of the domains was calculated using Cronbach’s alpha.  
 
Results 
 
Participant characteristics are described in Table 1. We excluded one participant with 
extensive missing data and one participant who was outside the age limit, leaving 228 
evaluable participants. Both genders were equally represented (51% female). Most 
participants were between 50 – 54 years (47%), and had sun-sensitive phenotypic 
characteristics (blue/grey eye colour 48%, fair complexion 85%). Half of participants had had 
a skin cancer removed previously, only one had used mobile teledermoscopy previously. 
Ninety-two per cent of participants who completed the follow-up survey had an iPhone 4 or 
5. 
Pre-teledermoscopy  
Overall, 13 out of 27 (48%) items were rated as ‘strongly agree’ or ‘agree’ by 75% or more 
of the participants (Table 2). Participants on average agreed (median= 3) with all items in the 
domains perceived ease of use, facilitators, subjective norm, attitude/intention and perceived 
usefulness. Participants reported neutral viewpoints (median =2) when asked whether they 
would have ‘complete trust’ in the teledermatologists telediagnosis, and were unsure if 
mobile teledermoscopy ‘would fit in with their current habits’.  Participants who had a 
previous skin cancer removed compared to participants without prior skin cancer were more 
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likely to agree with the items: ‘Mobile teledermoscopy will help to diagnoses skin cancer 
quicker’ (80% compared to 69%, p=0.01); ‘Diagnosis of a suspicious mole or spot made 
through mobile teledermoscopy would be clear and easily understandable’ (54% compared to 
47%, p=0.04), and ‘My doctor will welcome the fact that I use mobile teledermoscopy’(61% 
compared to 51%, p=0.04)  (Table 2). There was no difference in teledermoscopy acceptance 
for participants who had one or more moles on their upper arm, versus those who did not any 
have moles (data not shown). 
Post-teledermoscopy  
Most participants who conducted mobile teledermoscopy (42/49; 86%) agreed mobile 
teledermoscopy motivated them to conduct SSE regularly and the dermatoscope was easy to 
use (46/49; 94%). On average, participants were confident taking photos with the 
dermatoscope (median=8, scale 1 not at all confident to 10 highly confident, range 4-10). 
Most participants (38/49; 78%) wished to use mobile teledermoscopy again in the future.  
 
Sixty-five per cent of participants (32/49) experienced no difficulties when conducting 
mobile teledermoscopy. Barriers reported by participants included: 9/49 (18%) could not take 
a photo in a ‘hard to see’ body location; and 7/49 (14%) had difficulty submitting the photo 
to the teledermatologist. Difficulties included not being able to connect to an internet account 
on their iPhone, sequencing or labelling of images or personalising the app. Thirty-five per 
cent of participants (17/49) required help from their partner, child, friend or study personnel 
when submitting photos on their iPhone. Most participants (36/49, 74%) had someone assist 
with taking photos including their partner, child or sibling. The majority of participants 
(37/49, 75%) did not experience any worry or distress waiting for their results, however, 6/49 
participants felt anxious conducting mobile teledermoscopy. One participant had difficulty 
understanding the study instructions provided and two participants were unable to take clear 
photos. Forty-one participants (84%) found the AC rule to be a good tool for finding moles to 
photograph, while six were unsure, and two disagreed (Table 3).  
 
Open ended responses 
Seventeen participants responded to the open-ended question. Participants provided positive 
feedback: “Fascinating to see the skin close up. Every home should have one 
[dermatoscope]!”; “A very worthwhile study. Would be handy to monitor changes yourself 
with a dermatoscope.” The dermatoscope was a prompt for action. “Having an opportunity 
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to use the dermatoscope reminded me of the importance of self-examination…, as I had not 
been for my regular skin check-up with my dermatologist for two years in spite of my brother 
diagnosed with a melanoma.” 
 
Participants noted concerns in particular about trust in the telediagnosis compared to in-
person consultations and the need for training. “It was an initial good tool, however, I am not 
a specialist and so I will not feel happy until you provide me with a full skin exam, then I'll 
know if my skills are ok”;  “Generally I feel that I would prefer to have a professional 
examine me for melanoma, but I can appreciate the value of the dermatoscope if I lived in a 
rural or remote region.” Others commented:  “The concept of self-diagnosis is excellent, 
given the immediacy of the possible response, but it is dependent on the competence of the 
individual”; and a participant noted the difficulty of imaging numerous dysplastic naevi 
clustered together, “I have so many moles on my back it was hard to label which was which 
for this study.”  
 
Discussion 
We found that a high proportion of participants (78%) would use mobile teledermoscopy 
again in the future after experiencing it in this study. Mobile teledermoscopy was well-
received and reported to be an easy process to conduct, that reinforced the importance of SSE 
for melanoma early detection. In the pre-teledermoscopy questionnaire almost all participants 
agreed with the items in the domains perceived ease of use, perceived usefulness, intention 
and attitude, facilitators, and subjective norm, while trust and compatibility received some 
neutral ratings.  
 
This study is unique in that it i) uses mobile teledermoscopy, which involves a more intricate 
image acquisition process than teledermatology, allowing higher image quality, and ii)  
focuses on self-completed SSE in the home environment. In contrast most previous research 
assessed satisfaction with store and forward teledermatology conducted in health professional 
settings,
21-25
 whereby nurses or general practitioners take the images. Preference for mobile 
teledermoscopy in this format varies. For example, in one study on store and forward 
teledermatology, participants did not express a clear preference for a consult method, 42% of 
participants agreed they would rather use teledermatology, 22% were unsure, and 37% 
preferred in-person consultations.
21
 Collins et al. found no difference in satisfaction between  
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in-person or mobile teledermoscopy consultation, with both groups pleased with the service. 
24
  
 
Only one small study previously assessed the feasibility of mobile teledermoscopy during a 
home SSE. 
16
  Similar to the findings here, the ten participants learned to use the technology 
with ease, but the study was limited by its very small sample size. Wu et al. assessed patient-
performed mobile teledermoscopy for monitoring of skin lesions identified by a doctor during 
an in-person consultation.
26
 The doctor completed the imaging process at the initial 
consultation and three to four months later the patient completed the imaging process for the 
same lesion in the office-setting. Most participants did not report any barriers to use, except 
the patient’s desire to see a dermatologist in-person.26 Trust in the telediagnosis is a potential 
barrier to use as expressed by some participants in the current study who would prefer an in-
person consultation. The qualitative comments indicate that training and reassurance that they 
self-selected the correct lesions could improve trust in subsequent rounds. Most participants 
were satisfied with the AC rule in this research. However in the qualitative comments some 
participants raised concerns about their own ability to find the most relevant skin lesions. No 
randomised clinical trial has been performed to demonstrate that using the AC rule or the 
more common ABCDE rule during mobile teledermoscopy improves the accuracy of 
laypersons to self-detect melanoma.
27
 
 
Other barriers reported by participants in this study included: difficulty taking photos in hard 
to see locations; and experiencing anxiety in the period of waiting for a telediagnosis. Mobile 
teledermoscopy may not be practical for whole body skin examinations for persons without 
access to help. The benefits of having well-trained partners assist in conducting skin checks 
in hard-to-see locations have been previously reported.
28,29
 Participants’ anxiety levels may 
have increased owing to a longer delay in receiving results than we found in previous studies. 
The waiting time in this study was due to only having one dermatologist reviewing the 
photos. Previous research found participants would prefer to receive their results after 
conducting mobile teledermoscopy “up to 1 day” later.30 To reduce any anxiety when 
conducting mobile teledermoscopy, provision of results would need to be streamlined to 
provide a prompt service.  
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The present study included an older age demographic, and a barrier among a minority of 
participants was downloading and personalising the app. Younger patients may have fewer 
technological issues, and may be more inclined to trust a mobile diagnosis, given their greater 
likelihood to also conduct other aspects of their life online. In this research most participants 
indicated they would use mobile teledermoscopy if it saved them money. Many people own a 
Smartphone and therefore they already have available part of the equipment needed to 
conduct mobile teledermoscopy.
31
 Cost and technical support were found to contribute to 
user acceptance of telemedicine in a qualitative European study about user-end adoption of 
home telemedicine among adults 55-75 years of age. 
32
 The cost of the most recent mobile 
dermatoscopes for smartphones ranges widely from about US$50 to US$600, but less costly 
innovative solutions may come forward in the future. 
 
We are cautious of generalising our findings to other settings, as we studied a relatively 
homogenous sample of patients at high-risk for melanoma. However, implementation of this 
technology would likely focus on high-risk groups once it is rolled out, and so our restriction 
to high-risk patients was not unreasonable. Arguably, rural populations have the most to gain 
from telemedicine services, and although this research was completed in an urban population, 
participants nonetheless reported high acceptance presumably as they can also benefit from 
time-savings, and appreciated the potential for rapid diagnosis. The items in the compatibility 
domain had a low Cronbach alpha. The items may not fully discriminate compatibility 
because it is difficult to measure a new technology especially if individuals have not used 
mobile teledermoscopy to know how compatible it is. Therefore their scores might be 
inconsistent and contribute to a low Cronbach alpha. These domains would require further 
development and items to be added in future questionnaire use. 
 
Despite high levels of acceptance and enthusiasm in this sample at high risk of melanoma, 
many practical aspects still need to be resolved before mobile teledermoscopy is ready for 
widespread consumer use. Further diagnostic studies to optimise acceptability and confidence 
of use are required to build consumer trust in the telediagnosis. 
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Figure 1 Legend 
iPhone 5 with dermatoscope attachment.  
Figure 3 Legend 
Image selected and photographed by participant. Telediagnosis BCC. Confirmed at 
histopathology. 
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Table 1 Participant Characteristics 
 
 
 
Characteristic 
Pre-teledermoscopy 
survey 
n (%) 
Post-teledermoscopy 
n (%) 
Total 
Gender 
n=228 n=49 
     Male  111 (48.7) 24 (49.0) 
     Female 117 (51.3) 25 (51.0) 
Age   
     50-54 108 (47.4) 19 (38.8) 
     55-59 78 (34.2) 16 (32.7) 
     60-64 42 (18.4) 14 (28.6) 
Educational attainment*   
     Primary school or leaving certificate 23 (10.1) 4 (8.2) 
     High School or trade 44 (19.3) 8 (16.3) 
     University degree/ diploma 157 (68.9) 36 (73.5) 
Work   
     Full-time (including self-employed)  134 (58.8) 38 (77.6) 
     Part-time  33 (14.5) 3 (6.1) 
     Other/did not specify 61 (26.7) 8 (16.3) 
Marital status*   
     Living with partner  185 (81.1) 41 (83.7) 
     Living without partner 42 (18.4) 8 (16.3) 
Previous skin cancer excised   
     Yes 114 (50.0) 24 (49.0) 
     No or unsure 114 (50.0) 25 (51.0) 
Skin type   
     Fair 193 (84.6) 44 (89.8) 
     Medium 32 (14.0) 4 (8.2) 
     Dark 3 (1.3) 1 (2.0) 
Moles larger than 2mm on upper arm   
     0 moles 
     1-10 moles 
     11+ moles 
97 (42.5) 
108 (47.4) 
23 (10.1) 
18 (36.7) 
24 (49.0) 
7 (14.3) 
Eye colour*   
     Blue/Grey 110 (48.2) 19 (38.8) 
     Green 29 (12.7) 6 (12.2) 
     Hazel/ Brown 85 (37.3) 24 (49.0) 
     Other (more than 1 colour) 3 (1.3) - 
*4 missing education, 1 missing marital status, 1 missing eye colour in pre-teledermoscopy survey;   
*1 missing education in post-teledermoscopy survey. 
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Table 2 Pre-teledermoscopy survey   
Items n (%) Skin cancer 
excised 
n (%) 
No personal 
skin cancer 
history 
P-value Cronbach 
alpha 
 n=228 n=114 n=114   
Perceived Usefulness     0.83 
MTD will help me to examine my 
skin more rapidly † 
   0.64  
Agree 174 (76.3) 94 (82.5) 97 (85.1)   
Unsure 44 (19.3) 15 (13.2) 15 (13.2)   
Disagree 9 (3.9) 5 (4.4) 2 (1.8)   
MTD will improve my skin self-
examination performance  
   0.99  
Agree 198 (86.8) 99 (86.8) 99 (86.8)   
Unsure 24 (10.5) 12 (10.5) 12 (10.5)   
Disagree 6 (2.6) 3 (2.6) 3 (2.6)   
The use of MTD will improve the 
diagnosis of  spots and moles on 
my skin that look suspicious  
   0.09  
Agree 194 (85.1) 93 (81.6) 101 (88.6)   
Unsure 30 (13.2) 17 (14.9) 13 (11.4)   
     Disagree 4 (1.8) 4 (3.5) -   
MTD will help me save time       0.91  
Agree 134 (58.8) 68 (59.6) 66 (57.9)   
Unsure 79 (34.6) 38 (33.3) 41 (36.0)   
Disagree 15 (6.6) 8 (7.0) 7 (6.1)   
MTD will help to diagnose skin 
cancer quicker 
   0.01  
Agree 170 (74.6) 91 (79.8) 79 (69.3)   
Unsure 55 (24.1) 20 (17.5) 35 (30.7)   
Disagree 3 (1.3) 3 (2.6) -   
Perceived Ease of Use    0.80 
It will be easy to perform MTD      0.63  
Agree 149 (65.4) 75 (65.8) 74 (64.9)   
Unsure 77 (33.8) 39 (24.2) 38 (33.3)   
Disagree 2 (0.9) - 2 (1.8)   
I will easily learn how to use 
MTD 
     0.77  
Agree 197 (86.4) 100 (87.7) 97 (85.1)   
Unsure 28 (12.3) 13 (11.4) 15 (13.2)   
Disagree 3 (1.3) 1 (0.9) 2 (1.8)   
Diagnosis of a suspicious mole or 
spot made through MTD would 
be clear and easily 
understandable 
     0.04  
Agree 115 (50.4) 61 (53.5) 54 (47.4)   
Unsure 107 (46.9) 53 (46.5) 54 (47.4)   
Disagree 6 (2.6) - 6 (5.3)   
I will find it easy to acquire the 
necessary skills to use MTD 
     0.81  
Agree 194 (85.1) 96 (84.2) 98 (86.0)   
Unsure 29 (12.7) 16 (14.0) 13 (11.4)   
Disagree 5 (2.2) 2 (1.8) 3 (2.6)   
Compatibility     0.48 
MTD will help me to examine my 
skin more thoroughly 
     0.99  
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Agree 203 (89.0) 101 (88.6) 102 (89.5)   
Unsure 20 (8.8) 10 (8.8) 10 (8.8)   
Disagree 5 (2.2) 3 (2.6) 2 (1.8)   
The use of MTD will involve 
major changes in my skin self-
examination practice 
    0.78  
Agree 156 (68.4) 79 (69.3) 77 (67.5)   
Unsure 50 (21.9) 23 (20.2) 27 (23.7)   
Disagree 22 (9.6) 12 (10.5) 10 (8.8)   
The use of MTD fits with my 
current skin self-examination 
habits  
    0.23  
Agree 154 (67.5) 55 (48.2) 44 (38.6)   
Unsure 43 (18.9) 28 (24.6) 39 (34.2)   
Disagree 31 (13.6) 31 (27.2) 31 (27.2)   
The use of MTD may interfere 
with my usual skin self-
examination  
    0.31  
Agree 6 (2.6) 3 (2.6) 3 (2.6)   
Unsure 39 (17.1) 15 (13.2) 24 (21.1)   
Disagree 183 (80.3) 96 (84.2) 87 (76.3)   
Intention and attitude     0.84 
I will use MTD when it is offered 
to me  
   0.88  
Agree 203 (89.0) 103 (90.4) 100 (87.7)   
Unsure 19 (8.3) 8 (7.0) 11 (9.6)   
Disagree 6 (2.6) 3 (2.6) 3 (2.6)   
I will use MTD routinely when I 
do skin self-examination in the 
future  
   0.54  
Agree 168 (73.7) 86 (75.4) 82 (71.9)   
Unsure 52 (22.8) 23 (20.2) 29 (25.4)   
Disagree 8 (3.5) 5 (4.4) 3 (2.6)   
I will use MTD if it will save me 
time  
   0.52  
Agree 172 (75.4) 88 (77.2) 84 (73.7)   
Unsure 30 (13.2) 12 (10.5) 18 (15.8)   
Disagree 26 (11.4) 14 (12.3) 12 (10.5)   
I will use MTD if it will save me 
money  
   0.72  
Agree 154 (67.5) 80 (70.2) 74 (64.9)   
Unsure 43 (18.9) 20 (17.5) 23 (20.2)   
Disagree 31 (13.6) 14 (12.3) 17 (14.9)   
In general, MTD will be useful to 
improve diagnosis of skin cancer  
   0.30  
Agree 201 (88.2) 104 (91.2) 97 (85.1)   
Unsure 25 (11.0) 9 (7.9) 16 (14.0)   
Disagree 2 (0.9) 1 (0.9) 1 (0.9)   
Participating in MTD will be in 
my best interests  
   0.99  
Agree 208 (91.2) 104 (91.2) 104 (91.2)   
Unsure 18 (7.9) 9 (7.9) 9 (7.9)   
Disagree 2 (0.9) 1 (0.9) 1 (0.9)   
Subjective Norm     0.77 
Other health professionals 
(physicians, nurses, other 
specialists etc.) will welcome the 
fact that I use MTD  
   0.81  
Agree 120 (52.6) 63 (55.3) 57 (50.0)   
Unsure 104 (45.6) 49 (43.0) 55 (48.2)   
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Disagree 4 (1.8) 2 (1.8) 2 (1.8)   
Most of my friends or family will 
welcome the fact that I use MTD 
   0.21  
Agree 154 (67.5) 83 (72.8) 71 (62.3)   
Unsure 65 (28.5) 28 (24.6) 37 (32.5)   
Disagree 9 (3.9) 3 (2.6) 6 (5.3)   
My doctor will welcome the fact 
that I use MTD 
   0.04  
Agree 170 (55.7) 69 (60.5) 58 (50.9)   
Unsure 55 (43.0) 42 (36.8) 56 (49.1)   
Disagree 3 (1.3) 3 (2.6) -   
Trust     0.78 
I will have complete trust in the 
dermatologist’s diagnosis based 
on a photo I emailed as part of 
MTD 
   0.85  
Agree 107 (46.9) 63 (55.3) 64 (56.1)   
Unsure 104 (45.6) 41 (36.0) 38 (33.3)   
Disagree 17 (7.5) 10 (8.8) 12 (10.5)   
I will rely on the teledermatology 
process to supply accurate 
information about a mole or spot 
   0.96  
Agree 127 (55.7) 54 (47.4) 53 (46.5)   
Unsure 79 (34.6) 51 (44.7) 53 (46.5)   
Disagree 22 (9.6) 9 (7.9) 8 (7.0)   
Facilitator      0.68 
I will use MTD if I receive 
adequate training  
   0.40  
Agree 210 (91.1) 106 (93.0) 104 (91.2)   
Unsure 10 (4.4) 3 (2.6) 7 (6.1)   
Disagree 8 (3.5) 5 (4.4) 3 (2.6)   
I will use MTD if I receive 
technical assistance when I need 
it  
   0.88  
Agree 194 (85.1) 96 (84.2) 98 (86.0)   
Unsure 24 (10.5) 12 (10.5) 12 (10.5)   
Disagree 10 (4.4) 6 (5.3) 4 (3.5)   
There are health professionals 
available who will help me with 
MTD  
   0.99  
Agree 132 (57.9) 66 (57.9) 66 (57.9)   
Unsure 95 (41.7) 48 (42.1) 47 (41.2)   
Disagree 1 (0.4) - 1 (0.9)   
†1 participant missing; MTD= mobile teledermoscopy; strongly agree and agree 
combined into a single agreement category; strongly disagree and disagree 
combined into a single disagreement category. 
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Table 3  
Satisfaction with mobile teledermoscopy for melanoma screening  
Items 
n (%) 
n=49 
Taking photos with the dermatoscope attachment was easy*  
Agree 46 (93.9) 
Unsure 1 (2.0) 
Disagree - 
Having the dermatoscope has motivated me to do skin 
examinations on myself more regularly 
 
Agree 42 (85.7) 
Unsure 3 (6.1) 
Disagree 4 (8.1) 
Conducting a whole body skin examination was easy  
Agree 26 (53.1) 
Unsure 9 (18.4) 
     Disagree 14 (28.5) 
Would you wish to send photos to a doctor to assist you in 
checking your own skin in the future? 
 
Yes 38 (77.6) 
Unsure 4 (8.2) 
No 7 (14.3) 
Did you experience any difficulties when photographing your 
moles or skin spots? 
 
Yes 17 (34.7) 
No 32 (65.3) 
If yes, what experiences did you find difficult? (select all that 
apply) 
 
I could not understand the instructions 1 (2.0) 
I could not download the Handyscope FotoFinder app - 
I could not take a clear or close-up photo of a particular 
mole or spot 
2 (4.1) 
I could not photograph a particular mole or skin spot     
because it was in a hard-to-see location or angle 
9 (18.4) 
I had difficulty personalising the app functions (for e.g. 
entering my study ID, gender, birth date)    
3 (6.1) 
I had difficulty sending the e-mail to the study 
dermatologist 
7 (14.3) 
Did you ask another person to help you photograph your moles 
or skin spots? 
 
Yes 36 (73.5) 
No 13 (26.5) 
By taking pictures of your spots or moles, did you feel 
distressed, anxious or worried about these spots or moles?* 
 
Yes 6 (12.2) 
Don’t know 4 (8.2) 
No 37 (75.5) 
Did you find the AC (asymmetry, colour) Rule to be a good tool 
to guide you in finding spots or moles to photograph? 
 
Yes 41 (83.7) 
Don’t know 6 (12.2) 
No 2 (4.1) 
*answer missing from 2 participants 
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Figure 2. Participant Recruitment 
 
 
 
 
Assessed for eligibility (n= 559) 
  larger cohort study (n=500) 
  media channels (n=59) 
Excluded (n=299) 
   Not meeting inclusion criteria e.g. 
age, residence (n=17) 
   Declined to participate or lost to 
follow-up (n=281) 
 
Sent pre-teledermoscopy survey  
(n= 261) 
Completion of pre-teledermoscopy survey 
(n=228) 
 
Excluded (n= 31) 
   Declined to participate (n=10) 
   Lost to follow-up (n=21) 
   Only partially completed survey (n=1) 
   Outside age limit (n=1) 
 
 
First 58 participants to return survey and have 
access to iPhone conducted teledermoscopy 
 
49 participants conducted mobile teledermoscopy 
and completed post-teledermoscopy survey 
 
Discontinued (n= 9) 
 Moved interstate/ overseas (n=2) 
 Lost access to an iPhone (n=1) 
 Did not attend in-person skin exam (n=2) 
 Damaged the dermatoscope (n=1) 
 Insufficient time (n=1) 
 Instructions were too complicated (n=1) 
 Outside age limit (n=1) 
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